Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer compared with the standard PSA test.
By HealthDay Staff HealthDay ReporterFRIDAY, June 26, 2026 (HealthDay News) — A next-generation blood test could improve ...
A groundbreaking blood test could enable doctors to identify failing prostate cancer treatment earlier, a trial found. Experts believe this discovery could lead to personalised therapies and extend ...
The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...
Think you know the signs of prostate cancer? Discover the subtle urinary changes many men ignore that could be a vital early ...
A new study found the Stockholm3 blood test detected aggressive prostate cancer more accurately than the standard PSA test. Researchers said the test could improve early detection while reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results